Redeye gives its view on today’s news related to the increased interest in CariSolv as an effect of the corona crisis. Even though the company’s main focus going forward will be on ChloraSolv and wound care products, we see today’s news as very positive and as a validation of the potential in the company’s unique buffered hypochlorite platform.